Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About this market
High potential for new techniques in metabolomics to emerge as a major trend. New techniques in metabolomics are gaining widespread popularity among scientists and researchers due to their increased potential for fast and simultaneous fingerprinting of a vast number of metabolites. Many of the above professionals use multiple separation techniques such as high-performance liquid chromatography (HPLC), UPLC, ion chromatography-mass spectrometry (IC-MS), GC, and LC, and other detection techniques such as MS-NMR, surface-based mass analysis, and metabolite profiling for successful and comprehensive metabolite coverage. ’ s analysts have predicted that the metabolomics market will register a CAGR of nearly 12% by 2023.
Market Overview
Rising demand for early and accurate diagnosis
In recent years, the field of metabolomics has shown significant potential in early disease diagnosis, therapy monitoring, and understanding the pathogenesis of different diseases. Since metabolomics methods focus on analytical techniques such as N MR spectroscopy and MS, the analyses from these high-resolution methods using advanced chemometric approaches can provide a powerful platform for translational/clinical research and diagnostic applications.
Lack of skilled professionals
Research analysis of samples using metabolomics tools requires the assistance of skilled professionals to design experiments, collect the samples, extract the samples, and generate metabolomic data. These professionals must have in-depth knowledge of analytical methods such as mass spectrometry and nuclear magnetic resonance, which are used in performing experiments.
For the detailed list of factors that will drive and challenge the growth of the metabolomics market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Bruker and Human Metabolome Technologies the competitive environment is quite intense. Factors such as the rising demand for early and accurate diagnosis and the high potential for new techniques in metabolomics, will provide considerable growth opportunities to metabolomics manufactures. Agilent Technologies, Bio-Rad Laboratories, Bruker, Human Metabolome Technologies, and METABOLON are some of the major companies covered in this report.
High potential for new techniques in metabolomics to emerge as a major trend. New techniques in metabolomics are gaining widespread popularity among scientists and researchers due to their increased potential for fast and simultaneous fingerprinting of a vast number of metabolites. Many of the above professionals use multiple separation techniques such as high-performance liquid chromatography (HPLC), UPLC, ion chromatography-mass spectrometry (IC-MS), GC, and LC, and other detection techniques such as MS-NMR, surface-based mass analysis, and metabolite profiling for successful and comprehensive metabolite coverage. ’ s analysts have predicted that the metabolomics market will register a CAGR of nearly 12% by 2023.
Market Overview
Rising demand for early and accurate diagnosis
In recent years, the field of metabolomics has shown significant potential in early disease diagnosis, therapy monitoring, and understanding the pathogenesis of different diseases. Since metabolomics methods focus on analytical techniques such as N MR spectroscopy and MS, the analyses from these high-resolution methods using advanced chemometric approaches can provide a powerful platform for translational/clinical research and diagnostic applications.
Lack of skilled professionals
Research analysis of samples using metabolomics tools requires the assistance of skilled professionals to design experiments, collect the samples, extract the samples, and generate metabolomic data. These professionals must have in-depth knowledge of analytical methods such as mass spectrometry and nuclear magnetic resonance, which are used in performing experiments.
For the detailed list of factors that will drive and challenge the growth of the metabolomics market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Bruker and Human Metabolome Technologies the competitive environment is quite intense. Factors such as the rising demand for early and accurate diagnosis and the high potential for new techniques in metabolomics, will provide considerable growth opportunities to metabolomics manufactures. Agilent Technologies, Bio-Rad Laboratories, Bruker, Human Metabolome Technologies, and METABOLON are some of the major companies covered in this report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
